Identifying promising companies, backing them, and supporting growth toward a profitable exit:
this is a fund in this classic form.

However, norms are meant to be challenged.

Every company we back enters an integrated platform where regulatory navigation, clinical evidence building, and market access strategy work in parallel with financing. This holistic approach can transform a promising venture into an acquirable, deployment-ready asset.

And if you’re wondering how this works, all you have to do is check our portfolio.

Our Portfolio

Meet our proactive side. If a breakthrough concept presents a market opportunity where no existing startup exists, we build one.

From scratch, in-house.

As long as it checks all regulatory, implementative, and financial boxes, the origin is irrelevant. We focus on providing the full venture formation infrastructure: capital, strategy, clinical planning, and practical support.

Such an early entry has nothing but advantages for us, from higher ownership percentage to more efficient outcome control.

This is the element that raises ARETI Europe

to a level most funds can’t replicate.

Evnia Group is an affiliated medical, clinical, regulatory, and quality science organization that provides operational infrastructure, including regulatory experts, clinical
trial capacity, hospital networks, quality management systems, and reimbursement specialists.

An integral layer of know-how and experience that sets the bar at new heights.